DEREK D MUSE
Allopathic & Osteopathic Physicians|Family Medicine SALT LAKE CITY, UT NPI 1720157555
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine UT Merck Sharp & Dohme Corporation All categories
General Payments — all program years on this page
$13,900.45
- Category: General Payments
- Program years: PY2018–2024
- Record count: 375
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,922.07 across 52 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,109.71 | 48 |
| Travel and Lodging | $812.36 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $1,159.87 | 9 |
| ABBVIE INC. | $268.21 | 14 |
| Astellas Pharma US Inc | $56.46 | 3 |
| Acerta Pharma LLC | $46.20 | 3 |
| PFIZER INC. | $44.51 | 3 |
| IDORSIA PHARMACEUTICALS US INC | $41.52 | 3 |
| Exact Sciences Corporation | $38.60 | 2 |
| Novo Nordisk AS | $36.96 | 2 |
| Corium, Inc. | $35.04 | 2 |
| Lilly USA, LLC | $32.76 | 2 |
| GlaxoSmithKline, LLC. | $31.41 | 2 |
| Otsuka America Pharmaceutical, Inc. | $23.00 | 1 |
| Inspire Medical Systems, Inc. | $20.91 | 1 |
| Amgen Inc. | $18.92 | 1 |
| SHIELD THERAPEUTICS INC | $18.75 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.14 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $16.50 | 1 |
| Janssen Pharmaceuticals, Inc | $15.31 | 1 |
By program year
Records — PY2024 (52)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.